Researchers evaluated data on more than 50,800 participants with rheumatoid arthritis to determine the risk for venous thromboembolism with tofacitinib vs TNF inhibitors.
Since ankylosing spondylitis can impact individuals who are of working age, researchers sought to determine the disease’s impact on overall work stability.
As the opioid epidemic continues to plague the United States, non-pharmacologic interventions for pain are increasingly important. With this in mind, researchers aimed to investigate the impact of early...
Researchers analyzed data on more than 23,900 participants with rheumatoid arthritis to determine whether there is an association between time-varying methotrexate use and cardiovascular event risk.
The American College of Rheumatology and National Psoriasis Foundation released a guideline of recommendations for active PsA among treatment‐naïve individuals.
Researchers analyzed whether C-reactive protein level can be used to predict how a patient with ankylosing spondylitis will react to tumor necrosis factor-α blocker treatment.
Researchers evaluated data on more than 60,000 patients to determine the clinical advantage of multibiomarker disease activity testing in rheumatoid arthritis management.
Researchers evaluated data on more than 60,000 patients to determine the clinical advantage of multibiomarker disease activity testing in rheumatoid arthritis management.
To allow heath care providers to make the most informed treatment decisions for ankylosing spondylitis, researchers evaluated the efficacy and safety of long-term use of secukinumab.
